Partner Jason Jardine was quoted in, “Covid-19: fledgling vaccination programmes leave poorer nations and vulnerable groups behind,” which was published in Market Screener.
Excerpt: “Jardine believes regulatory issues are more of a problem for developing nations than patents, with no government able to begin their own programme of inoculation until a vaccine has been passed by its regulators.”
